Galenica is a Swedish privately owned pharmaceutical company, authorized and audited by the Swedish Medical Product Agency. Galenica was founded in 1999 and has dedicated employees with expertise and balance between academic knowledge and industrial experience. Galenica is located in Medeon Science Park with 4000 m² state-of-the-art facilities.

Our activities are divided into two business units: Contract Development Manufacturing Organization (CDMO) and Development and launching of own branded pharmaceutical products (PHARMA).

Within CDMO, Galenica supports and guides our partners in their pharmaceutical development programs and manufactures commercially niched products for our customers to bring to the market. We have vast expertise in pharmaceutical and analytical development as well as in production of Clinical Trial Material (CTM) for Phase I up to Phase III of all common non-sterile dosage forms.

The PHARMA unit actively develops and launches our own pharmaceutical products which has a focus on derma, utilizing our state-of-the-art expertise in drug formulation, manufacturing, and quality control.

Galenica stands out as your trusted ally in the pharmaceutical industry. Our dedication to excellence in formulation development is complemented by our commitment to delivering quality results on time and within budget.